0001104659-18-017694 Sample Contracts

Contract

Collaboration Agreement • March 15th, 2018 • Adaptimmune Therapeutics PLC • Biological products, (no disgnostic substances) • England and Wales

• Contract Type
  Collaboration Agreement
• Filed
  March 15th, 2018
• Company
  Adaptimmune Therapeutics PLC
• Industry
  Biological products, (no disgnostic substances)
• Jurisdiction
  England and Wales

CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [***], HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 24B-2 UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED.

DATED 28 FEBRUARY 2018

Adaptimmune Therapeutics PLC • March 15th, 2018 • Biological products, (no disgnostic substances)

• Company
  Adaptimmune Therapeutics PLC
• Filed
  March 15th, 2018
• Industry
  Biological products, (no disgnostic substances)

FIRST AMENDMENT TO EMPLOYMENT AGREEMENT

Employment Agreement • March 15th, 2018 • Adaptimmune Therapeutics PLC • Biological products, (no disgnostic substances)

• Contract Type
  Employment Agreement
• Filed
  March 15th, 2018
• Company
  Adaptimmune Therapeutics PLC
• Industry
  Biological products, (no disgnostic substances)

THIS FIRST AMENDMENT TO EMPLOYMENT AGREEMENT (this “First Amendment”) is made effective as of October 30, 2017 (“Effective Date”) by and between Adaptimmune, LLC, a wholly-owned subsidiary of Adaptimmune Ltd. (“Company”), and Gwendolyn Binder-Scholl of Philadelphia, PA (“Executive”). Capitalized terms used and not otherwise defined herein shall have the meanings ascribed to such terms in the Employment Agreement (as defined below).